Adial Pharmaceuticals Statistics
Total Valuation
ADIL has a market cap or net worth of $6.85 million. The enterprise value is $1.65 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ADIL has 6.41 million shares outstanding. The number of shares has increased by 248.81% in one year.
Current Share Class | 6.41M |
Shares Outstanding | 6.41M |
Shares Change (YoY) | +248.81% |
Shares Change (QoQ) | +39.52% |
Owned by Insiders (%) | 1.51% |
Owned by Institutions (%) | 3.21% |
Float | 5.95M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.16 |
P/TBV Ratio | 1.17 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.78
Current Ratio | 6.78 |
Quick Ratio | 6.28 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -316.95% and return on invested capital (ROIC) is -123.55%.
Return on Equity (ROE) | -316.95% |
Return on Assets (ROA) | -106.05% |
Return on Capital (ROIC) | -123.55% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.86M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -248.81% |
Shareholder Yield | -248.81% |
Earnings Yield | -190.35% |
FCF Yield | -97.62% |
Analyst Forecast
The average price target for ADIL is $8.00, which is 647.66% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.00 |
Price Target Difference | 647.66% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Aug 7, 2023 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |